phrykt

Precigen, Inc. (PGEN): who owns it and who trades it

As of Nov 16, 2026, PGEN insiders reported 40 open-market sales worth $44.6M and 1 purchase worth $24.7K in the last 12 months, with 12% of the sale value made under pre-set 10b5-1 plans. The largest seller was Randal J Kirk (Director), with $35.8M. 6 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Precigen

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Funds and famous investors mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns PGEN

211 funds and institutions reported PGEN shares worth $807M at the end of Q2 2026, about 40% of the company. The largest holder is Patient Capital Management, LLC with 5.3%.

Funds and institutions (13F) 40%Everyone else 60%

10 largest owners, by share of the company

Patient Capital Management, LLC5.3%
BlackRock, Inc.4.8%
State Street Corp3.4%
Diametric Capital, LP2.6%
Vanguard Capital Management LLC2.2%
Tang Capital Management LLC1.8%
Boxer Capital Management, LLC1.4%
Geode Capital Management, LLC1.4%
Iridian Asset Management LLC1.1%
Occam Crest Management LP1.0%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Patient Capital Management, LLC19.04M5.34%$109M+7%
BlackRock, Inc.17.15M4.81%$97.7M+13%
State Street Corp12.00M3.37%$68.4M+10%
Diametric Capital, LP9.27M2.60%$52.8M+36%
Vanguard Capital Management LLC7.91M2.22%$45.1M+11%
Tang Capital Management LLC6.42M1.80%$36.6MNo change
Boxer Capital Management, LLC5.15M1.44%$29.4M+47%
Geode Capital Management, LLC5.02M1.41%$28.6M+9%
Iridian Asset Management LLC4.03M1.13%$23M+12%
Occam Crest Management LP3.61M1.01%$19.7M-16%
Morgan Stanley3.47M0.97%$19.8M+44%
Goldman Sachs Group Inc3.41M0.96%$19.4M+2%
FMR LLC (Fidelity)2.57M0.72%$14.7M+29%
Vanguard Portfolio Management LLC2.21M0.62%$12.6M+4%
First Trust Advisors LP2.01M0.57%$11.5M–
Bank of America Corp1.85M0.52%$10.5M+26%
Arrowstreet Capital, Limited Partnership1.79M0.50%$10.2M+352%
Northern Trust Corp1.78M0.50%$10.1M+10%
Charles Schwab Investment Management Inc1.52M0.43%$8.6M+4%
Sixth Street Partners Management Company, L.P.1.52M0.43%$8.6M–

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, PGEN insiders reported $24.7K of open-market purchases and $44.6M of sales. 12% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$24.7K
1 trades, 1 people
Sales, 12 months
$44.6M
40 trades, 7 people
Sales under a 10b5-1 plan
12%
Share of sale value
Latest trade
Aug 26, 2026
Filed Aug 28, 2026

Purchases and sales by month

$15.6M$15.6MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Aug 26, 2026Jeffrey B KindlerDirectorSale185,000$7.44$1.4MForm 4
Aug 25, 2026Rutul R ShahChief Operating OfficerSale plan15,342$7.50$115KForm 4
Aug 25, 2026Phil TennantChief Commercial OfficerSale plan79,166$7.50$594KForm 4
Aug 21, 2026Nancy H AgeeDirectorPurchase3,411$7.23$24.7KForm 4
Aug 21, 2026Rutul R ShahChief Operating OfficerSale plan34,658$7.50$260KForm 4
Aug 6, 2026Rutul R ShahChief Operating OfficerSale plan32,739$6.86$225KForm 4
Aug 3, 2026Rutul R ShahChief Operating OfficerSale plan33,772$6.50$220KForm 4
Jul 31, 2026Harry Thomasian Jr.CFOSale plan100,000$6.06$606KForm 4
Jul 1, 2026Harry Thomasian Jr.CFOSale plan171,429$5.53$948KForm 4
Jun 29, 2026Harry Thomasian Jr.CFOSale plan28,571$5.78$165KForm 4
Jun 29, 2026Rutul R ShahChief Operating OfficerSale plan42,924$5.85$251KForm 4
Jun 29, 2026Helen SabzevariCEOSale plan346,836$5.89$2MForm 4
May 28, 2026Harry Thomasian Jr.CFOSale41,884$4.36$183KForm 4
May 28, 2026Phil TennantChief Commercial OfficerSale30,272$4.36$132KForm 4
May 28, 2026Rutul R ShahChief Operating OfficerSale42,703$4.36$186KForm 4
May 28, 2026Donald P. LehrChief Legal OfficerSale29,131$4.36$127KForm 4
May 28, 2026Helen SabzevariCEOSale119,250$4.36$520KForm 4
Mar 30, 2026Randal J KirkDirectorSale47,101$3.30$155KForm 4
Mar 30, 2026Randal J KirkDirectorSale168,794$3.30$557KForm 4
Mar 30, 2026Randal J KirkDirectorSale426,199$3.30$1.4MForm 4
Mar 30, 2026Randal J KirkDirectorSale50,797$3.30$168KForm 4
Mar 30, 2026Randal J KirkDirectorSale152,063$3.30$502KForm 4
Mar 30, 2026Randal J KirkDirectorSale370,847$3.30$1.2MForm 4
Mar 30, 2026Randal J KirkDirectorSale23,789$3.30$78.5KForm 4
Mar 30, 2026Randal J KirkDirectorSale2.33M$3.30$7.7MForm 4
Mar 30, 2026Randal J KirkDirectorSale38,976$3.30$129KForm 4
Mar 30, 2026Randal J KirkDirectorSale1.11M$3.30$3.7MForm 4
Dec 22, 2025Randal J KirkDirectorSale956,200$4.18$4MForm 4
Dec 22, 2025Randal J KirkDirectorSale9,931$4.18$41.5KForm 4
Dec 22, 2025Randal J KirkDirectorSale5,958$4.18$24.9KForm 4
Dec 22, 2025Randal J KirkDirectorSale11,917$4.18$49.8KForm 4
Dec 22, 2025Randal J KirkDirectorSale42,702$4.18$178KForm 4
Dec 22, 2025Randal J KirkDirectorSale159,321$4.18$666KForm 4
Dec 22, 2025Randal J KirkDirectorSale12,909$4.18$54KForm 4
Dec 22, 2025Randal J KirkDirectorSale38,729$4.18$162KForm 4
Dec 22, 2025Randal J KirkDirectorSale94,341$4.18$394KForm 4
Dec 22, 2025Randal J KirkDirectorSale555,119$4.18$2.3MForm 4
Dec 12, 2025Jeffrey B KindlerDirectorSale235,467$3.63$855KForm 4
Nov 21, 2025Randal J KirkDirectorSale937,308$3.83$3.6MForm 4
Nov 20, 2025Randal J KirkDirectorSale942,832$4.08$3.8MForm 4
Nov 19, 2025Randal J KirkDirectorSale1.09M$4.47$4.9MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Randal J KirkDirector, 10% owner–$35.8MMar 30, 2026
Helen SabzevariPresident and CEO–$2.6MJun 29, 2026
Jeffrey B KindlerDirector–$2.2MAug 26, 2026
Harry Thomasian Jr.Chief Financial Officer–$1.9MJul 31, 2026
Rutul R ShahChief Operating Officer–$1.3MAug 25, 2026
Phil TennantChief Commercial Officer–$726KAug 25, 2026
Donald P. LehrChief Legal Officer–$127KMay 28, 2026
Nancy H AgeeDirector$24.7K–Aug 21, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

PGEN short interest

High short interest. 12.5% of PGEN shares are sold short: about 1 share in 8. Over the last 12 reports the number of shares short went up 13%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 44.91M PGEN shares were sold short, 12.5% of the shares outstanding, down 3.2% from the report before. At the average daily volume of 5.25M shares, buying them all back would take about 8.6 trading days (days to cover).

Shares short, % of all shares

12.5%May 15Oct 3013.6%

Days to cover

8.6May 15Oct 3017.8

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202644.91M12.53%-3%5.25M8.6
Oct 15, 202646.39M12.96%-2%4.54M10.2
Sep 30, 202647.55M13.28%+12%6.44M7.4
Sep 15, 202642.28M11.81%+0%2.60M16.3
Aug 31, 202642.18M11.78%-0%5.33M7.9
Aug 14, 202642.24M11.80%+0%7.21M5.8
Jul 31, 202642.04M11.74%+2%3.78M11.1
Jul 15, 202641.03M11.51%-7%4.26M9.6
Jun 30, 202644.22M12.40%+2%5.81M7.6
Jun 15, 202643.34M12.16%+8%5.87M7.4
May 29, 202640.25M11.29%+1%4.21M9.6
May 15, 202639.87M11.18%+0%3.61M11.1

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Precigen company events

Precigen filed 5 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 5, 2026.

  1. Nov 5, 2026ResultsReleased financial results. Filing
  2. Aug 4, 2026ResultsReleased financial results. Filing
  3. Jun 24, 2026LeadershipAt the Annual Meeting of Stockholders of Precigen, Inc. held on June 18, 2026, the Company’s stockholders approved an amendment to the Precigen, Inc. 2023 Omnibus Incentive Plan, as amended, to increase the number of shares of common stock available for issuance thereunder by 7 million. Filing
  4. May 13, 2026ResultsReleased financial results. Filing
  5. Mar 25, 2026ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Precigen financials

Famous investors that hold PGEN

6 of the 50 well-known investors we track reported holding PGEN in their latest 13F filing. The largest position is Steve Cohen's, worth $16.3M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Steve Cohen · Point72 Asset ManagementQ3 20261.90M$16.3M0.0%+50%
Ken Griffin · Citadel AdvisorsQ3 20261.55M$13.3M0.0%+89%
Jim Simons · Renaissance TechnologiesQ3 2026639,500$5.5M0.0%+6%
Paul Tudor Jones · Tudor Investment CorpQ3 2026157,400$1.3M0.0%New
Israel Englander · Millennium ManagementQ3 202667,112$574K0.0%-33%
Larry Robbins · Glenview Capital ManagementQ3 202622,200$190K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Precigen, Inc. (PGEN) stock

Who owns the most PGEN stock?

The largest reported owner of Precigen, Inc. (PGEN) is Patient Capital Management, LLC, with 5.3% of the company. In total, 211 funds and institutions reported holding PGEN at the end of Q2 2026, together about 40% of the shares. See the largest owners.

Are PGEN insiders buying or selling?

In the last 12 months, PGEN insiders reported 1 open-market purchase worth $24.7K and 40 sales worth $44.6M. The latest trade was on Aug 26, 2026. See every trade.

What is the short interest in PGEN?

As of Oct 30, 2026, 44.91M PGEN shares were sold short, 12.5% of the shares outstanding, down 3.2% from the report before. At the average daily volume of 5.25M shares, buying them all back would take about 8.6 trading days (days to cover). See the history.

Which famous investors hold PGEN?

6 of the 50 well-known investors we track reported PGEN in their latest 13F filing, including Steve Cohen, Ken Griffin, Jim Simons. The largest position is worth $16.3M. See all holders.

Executive pay

Precigen's chief executive was paid a total of $5.4M for the year ended Dec 31, 2025, down 1% from $5.4M the year before. In the last 12 months, Precigen's executives and directors bought $24.7K of stock on the open market and sold $44.6M.

Chief executive, total pay$5.4MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$18.6MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$1.4MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.